1/29
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
What are the causes of mitral valve regurgitation?

What is MMVD?
thickening and elongation of the valve leaflets, leads to valvular insufficiency (regurgitation) and volume overload of the left atrium & ventricle
75-80% of all canine heart disease (small dogs < 45 lbs and older dogs)
What are the symptom differences between early and progressive MMVD and MMVD with CHF?
Early: Asymptomatic; incidental left apical systolic murmur
Progressive: Cough (esp. night), exercise intolerance, tachypnea, restlessness
CHF: Dyspnea, syncope, collapse, +/- ascites if bivent failure)
How is MMVD diagnosed (not including echo)?
PE:
• Left apical systolic murmur
• +/- tachycardia, arrhythmia, dyspnea, crackles, weak pulses
ECG: ± sinus tachycardia, arrhythmias, large LA/LV patterns
Thoracic radiographs:
• Cardiomegaly over time (LA), with L bronchus compression
• LAA bulge at 3 o’clock on DV (“Bow-legged cowboy” sign = separation of mainstem bronchi)
• Lateral projection - tracheal elevation and left atrial bulge caudodorsal aspect of heart
• Pulmonary venous congestion
• Interstitial to alveolar pattern (pulmonary edema) if CHF
How does MMVD appear on an echo?
• Thickened mitral leaflets
• Mitral valve prolapse
• Mitral regurgitation +/- tricuspid regurgitation
• LV volume overload → LV, LA dilation - La:Ao ratio > 1.6 is significant
• May develop chordae tendinae rupture
• May develop pericardial effusion (If endocardial splitting and then LA tear)
• Less often develop pleural effusion
What can explain peracute worsening symptoms of MMVD?
ruptured chordae tendinae
What is the typical presentation of ruptured chordae tendinae?
acute LCHF
What are the clinical syndromes of MMVD?
• No clinical signs (asymptomatic murmur or click)
• Cough: Left mainstem bronchus compression, Early CHF
• Left sided congestive heart failure: Dyspnea due to pulmonary edema
• Ruptured chordae tendinae (acute L-CHF): Incidence ~15% (up to 70% of dogs with severe CHF)
• Syncope: Vasovagal syncope, tussive syncope, arrhythmia, pulmonary hypertension
• Endocardial split/LA tear: Cardiac tamponade
What are the big 4 of MMVD treatment?
• Furosemide
• Spironolactone
• Pimobendan
• ACE Inhibitor
What is the new combo therapy for MMVD?
cardalis = spironolactone/benazepril combination
What is stage A MMVD?
Dogs at higher than average risk for developing heart failure but without any apparent structural abnormality (ie. no murmur) → no treatment
What is stage B MMVD?
Structural abnormality (ie. MMVD) but no clinical signs of heart failure
Stage B1: Asymptomatic dogs with MV regurgitation from MMVD not severe enough to meet criteria used to trigger treatment
Stage B2: Asymptomatic dogs with MV regurgitation from MMVD severe enough to result in cardiac remodeling (LA/LV enlargement) sufficient to recommend treatment
What are the treatment options for stage B MMVD?
B1: No drug or dietary treatment is recommended → Reeval by echocardiography or radiography in 6-12 months
B2:
• Pimobendan
• Diet - mild sodium restriction, adequate protein/calories, highly palatable
• Angiotensin converting enzyme inhibitors (ACEI)
• Beta blockade is not recommended routinely to delay the onset of heart failure in dogs in Stage B2, regardless of heart enlargement
• Spironolactone is not recommended for routine use to delay the onset of heart failure although a pilot study suggests this approach should be used
What is stage C MMVD?
MMVD severe enough to cause current or past clinical signs of heart failure Hospitalized (Acute) vs Home (Chronic)
How is stage C MMVD diagnosed?
ECG, BP, Thoracic Radiographs, Echocardiogram, NT-proBNP
Normal/near normal [NT-proBNP] in dog w/ cough, dyspnea, or exercise intolerance = NOT CHF!!!
How is stage C MMVD treated?
Hospital/Acute:
• Furosemide, Oxygen, Pimobendan, Sedation PRN, Centesis PRN, Nursing care, Dobutamine/Sodium nitroprusside/ACEi/Nitroglycerin all PRN
Home/Chronic:
• Furosemide, Pimobendan, ACEi, Spironolactone
• Cough suppressants? Bronchodilators?
• Continue diet per Stage B, promote appetite PRN, adjust K/Mg PRN, omegas?
• Monitor BUN/Cr/Lytes!
• Inc. in resting RR above normal has best predictive value for impending clinical decompensation
What is stage D MMVD?
Patients have clinical signs of failure refractory to standard treatment for Stage C heart failure from MMVD
How is stage D MMVD treated?
Hospital/Acute:
• Furosemide higher dose or Torsemide (0.1-0.2 mg/kg q12h-q24h or approx 5%-10% of the current furosemide dosage to deliver a furosemide-equivalent dose)
• Centesis PRN, More potent afterload reduction, More Pimobendan?
• Sildenafil PRN if pulmonary hypertension
Home/Chronic:
• Furosemide/Torsemide, Hydrochlorothiazide?, Pimobendan, ACEi, Spironolactone, More afterload reduction, Cough suppressants? Bronchodilators?
• Continue diet per Stage B, promote appetite PRN, adjust K/Mg PRN, omegas?
• Monitor BUN/Cr/Lytes!
• Increase in resting respiratory rate above normal baseline has the best predictive value for impending clinical decompensation
What is the prognosis for MMVD?
• B1: Years, may never progress
• B2: 3.5 years to CHF with Pimobendan
• C: 6-12 months
• D: Weeks to months
What is the most common type of endocarditis?
valvular endocarditis
What are the complications associated with bacterial endocarditis?
thickening/fibrous valvular changes
vegetative lesions may create stenosis or insufficiency
What are the risk factors for bacterial endocarditis?
• Pre-existing valvular disease (esp. congenital SAS)
• Immunosuppressive drugs (28%)
• Middle aged, intact male large breed dogs (90%)
• Recent surgery
• Recent IV catheter placement
• Antimicrobial use (74%, often inadequate or inappropriate)
• Allergic factor (proposed for equine endocarditis)
What are the cardiac effects of bacterial endocarditis?
Mitral valve:
• Mitral regurgitation (systolic regurgitant quality murmur)
• Mitral stenosis (diastolic murmur)
• Left-sided CHF
Aortic valve:
• Aortic regurgitation (Diastolic murmur & bounding arterial pulses)
• Aortic stenosis (systolic ejection murmur)
• Left-sided CHF
Pulmonic and tricuspid valve:
• Tricuspid &/or pulmonic stenosis or insufficiency
• Right-sided CHF
• Pulmonary thromboembolism
What are the systemic effects of bacterial endocarditis?
• Pyelonephritis
• UTI
• Meningitis
• Septic arthropathy
• Myocarditis
• Immune mediated GN or polyarthritis
• Thrombosis can lead to infection or infarction (“bland thrombus”) - spleen, kidney, left ventricle, lungs, CNS, GI tract
What clinical scenarios are associated with bacterial endocarditis?
CHF
fever of unknown origin
multisystemic signs
organ embolism
What are the common clinical findings associated with bacterial endocarditis?
fever
leukocytosis
cardiac murmur
lameness
lethargy, anorexia depression
What diagnostic testing should be performed if suspecting bacterial endocarditis?
bartonella testing
arthrocentesis
blood and urine cultures
What are the echocardiographic findings of bacterial endocarditis?
• Thick, asymmetric, shaggy, hyperechoic vegetative valvular lesions
• Oscillating, vibratory, or mobile valvular lesions
• Cardiac chamber enlargement or hypertrophy
• Valvular regurgitation or stenosis
• Diagnostic accuracy 80-90%
• Transesophageal echocardiography: Better definition of structures at heart base, Improves diagnostic accuracy
How is bacterial endocarditis treated?
• Antibiotic based on culture & sensitivity or serology
• IV antibiotics for the first 5-14 days
• Broad spectrum antibiotics
• Oral antibiotics for 4 to 8 weeks
corticosteroids contraindicated and reduce survival
What is the prognosis of bacterial endocarditis?
Median survival 2 months (0-1,028 days)
Aortic valve 3 days vs. mitral valve 476 days
Worse prognosis if:
• CHF is already present at time of diagnosis
• Aortic valve is affected
• Gram negative sepsis
• Renal failure or increased creatinine
• Thrombocytopenia
• Thromboembolic complications
• Azotemia
• Treated with corticosteroids
• Large animal species? Cats?